Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wayne Pharmaceuticals is a private Georgia-based healthcare products company focused on biomedical research, product development, and commercialization of consumer health products. The company presents itself as an African American-owned pharmaceutical and biomedical enterprise with operations centered in Georgia, including a campus in Cordele that it describes as the MD Whitest Institute and Wayne Pharmaceutical Biomedical Research Center. Its publicly described commercial product is Dr. Wayne’s Aspirin, an enteric-coated low-dose aspirin product marketed for cardiovascular risk reduction and related consumer uses. The company also launched a DR WAYNE mobile app to distribute company updates and health information. Based on currently available public information, Wayne Pharmaceuticals appears to operate more as a small private healthcare products and brand-development company than as a traditional clinical-stage drug developer with a disclosed therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wayne Pharmaceuticals.